Liquid Biopsy Market Size Worth $19.35 Billion By 2028
Liquid Biopsy Industry Overview The global liquid biopsy market size was valued at USD 7.03 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 13.5% during the forecast period. The increasing prevalence of cancer coupled with the rise in demand for fast, minimally invasive diagnostic tests drives the market growth. According to the American Cancer Society, in 2021, 235,760 people are estimated to be diagnosed with non-small-cell lung cancer, the most common form of lung cancer in the U.S. Overall, around one in 17 men and one in 15 women are at risk of developing lung cancer in their lifetime. Thus, the need for the implementation of liquid biopsy tests is growing to diagnose and eradicate cancer in a target population. Gather more insights about the market drivers, restrains and growth of the Global Liquid Biopsy Market With the onset of the COVID-19 pandemic, cancer diagnoses are getting delayed as diagnosis services and screening programs ha...